Upregulation of ABLIM1 Differentiates Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma and Both Colorectal and Pancreatic Adenocarcinoma Liver Metastases
- Tina Draškovič 1, Branislava Ranković 1, Nina Zidar 1, Nina Hauptman 1
- 1Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
- 0Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study investigated gene expression in liver cancers, finding actin-binding LIM protein 1 (ABLIM1) is upregulated in cholangiocarcinoma, suggesting it as a potential biomarker for differentiating this cancer from others.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Altered gene expression in cancers offers potential for improved diagnostics and differentiation of primary and metastatic liver cancers.
- Investigated expression of protein-coding genes (RNF135, EFNB2, RNF125, HOXC4, ABLIM1, OSMR) and lncRNAs (PROX1-AS1, LIFR-AS1).
- Examined expression in hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases, and pancreatic ductal adenocarcinoma liver metastases.
Purpose Of The Study
- To investigate and compare the expression of specific genes and lncRNAs in various primary and metastatic liver cancers.
- To identify potential diagnostic biomarkers for differentiating between different types of liver malignancies.
Main Methods
- Analysis of 149 formalin-fixed, paraffin-embedded samples from 80 patients.
- RNA isolation, quantification, reverse transcription, and preamplification followed by real-time qPCR.
- Gene expression analysis using the ∆∆Cq method, AmiCA, and UCSC Xena platforms.
Main Results
- Differential gene and lncRNA expression observed between primary tumors and healthy tissues for all investigated markers.
- Downregulation of RNF135 in hepatocellular carcinoma and OSMR in colorectal liver metastases.
- Upregulation of HOXC4 in cholangiocarcinoma and a significant upregulation of ABLIM1 in cholangiocarcinoma compared to other liver cancers and healthy tissue.
Conclusions
- Understanding gene expression differences is crucial for diagnosing and differentiating healthy tissues from primary and metastatic liver cancers.
- Altered gene expression, particularly ABLIM1, shows potential as a diagnostic biomarker for cholangiocarcinoma.
- Highlights the utility of molecular markers in improving liver cancer diagnostics.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:24
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

